These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10723980)

  • 1. Reactivation of hepatitis B in patients with human immunodeficiency virus infection treated with combination antiretroviral therapy.
    Proia LA; Ngui SL; Kaur S; Kessler HA; Trenholme GM
    Am J Med; 2000 Feb; 108(3):249-51. PubMed ID: 10723980
    [No Abstract]   [Full Text] [Related]  

  • 2. Normalization of liver enzymes in an HIV-hepatitis C virus-co-infected patient after potent antiretroviral therapy.
    Diaz B; Martín-Carbonero L; Pérez-Olmeda M; Soriano V
    AIDS; 2002 May; 16(8):1193. PubMed ID: 12004283
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy.
    Vento S; Garofano T; Renzini C; Casali F; Ferraro T; Concia E
    AIDS; 1998 Jan; 12(1):116-7. PubMed ID: 9456265
    [No Abstract]   [Full Text] [Related]  

  • 4. Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy.
    Manegold C; Hannoun C; Wywiol A; Dietrich M; Polywka S; Chiwakata CB; Günther S
    Clin Infect Dis; 2001 Jan; 32(1):144-8. PubMed ID: 11118394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HIV patient with hepatic flare after the initiation of HBV-active antiretroviral therapy.
    Yoshida M; Hoshina T; Tamura K; Kawano S; Kato T; Sato F; Nakazawa Y; Yoshikawa K; Onodera S; Hori S
    Intern Med; 2012; 51(12):1623-6. PubMed ID: 22728503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between HIV and hepatitis B.
    Bonacini M
    AIDS; 1997 Nov; 11(14):1789-90. PubMed ID: 9386822
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV].
    Gavazzi G; Richallet G; Morand P; Bouchard O; Bosseray A; Leclercq P; Micoud M
    Pathol Biol (Paris); 1998 Jun; 46(6):412-5. PubMed ID: 9769871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patients.
    Valdez H; Metcalf JA; Gripshover BM; Jacobson JM; Mitsuyasu R; Lederman MM
    AIDS; 2001 Mar; 15(5):661-2. PubMed ID: 11317011
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus.
    Matthews-Greer JM; Caldito GC; Adley SD; Willis R; Mire AC; Jamison RM; McRae KL; King JW; Chang WL
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):690-4. PubMed ID: 11427412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.
    Wu PY; Cheng CY; Liu CE; Lee YC; Yang CJ; Tsai MS; Cheng SH; Lin SP; Lin DY; Wang NC; Lee YC; Sun HY; Tang HJ; Hung CC
    PLoS One; 2017; 12(2):e0171596. PubMed ID: 28222098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
    Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
    Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bilirubinemia and blood transaminase activity in certain stages of acute viral hepatitis B].
    Ilić V; Begic-Janev A; Perisić Z; Nikolić P; Bajić-Zlatković V
    Srp Arh Celok Lek; 1982 Jan; 110(1):43-7. PubMed ID: 7157062
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythema multiforme following the exacerbation of hepatitis B virus infection.
    Tabata N; Kato T; Noguchi K; Ueno Y; Tagami H
    Int J Dermatol; 1999 Jan; 38(1):52-3. PubMed ID: 10065611
    [No Abstract]   [Full Text] [Related]  

  • 16. Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
    Panos GZ; Lampropoulos KM; Angelousi AG; Charatsis GG; Falagas ME
    J Clin Gastroenterol; 2007 Feb; 41(2):222-3. PubMed ID: 17245225
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
    Tural C; Romeu J; Sirera G; Andreu D; Conejero M; Ruiz S; Jou A; Bonjoch A; Ruiz L; Arnó A; Clotet B
    J Infect Dis; 1998 Apr; 177(4):1080-3. PubMed ID: 9534987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker.
    Chamorro AJ; Casado JL; Bellido D; Moreno S
    Eur J Clin Microbiol Infect Dis; 2005 Jul; 24(7):492-4. PubMed ID: 15990987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of opportunistic infections in patients co-infected by HTLV-1 and HIV-1, with high CD4+ cells count.
    Regis C; Oliveira A; Brites C
    Braz J Infect Dis; 2009 Aug; 13(4):311-3. PubMed ID: 20231997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.
    Ingiliz P; Valantin MA; Duvivier C; Medja F; Dominguez S; Charlotte F; Tubiana R; Poynard T; Katlama C; Lombès A; Benhamou Y
    Hepatology; 2009 Feb; 49(2):436-42. PubMed ID: 19085967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.